New York State Common Retirement Fund’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

New York State Common Retirement Fund’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18,900	Closed	-$93K	–	3204
2016 Q4	$93K	Hold	18,900	–	–	﹤0.01%	2989
2016 Q3	$94K	Hold	18,900	–	–	﹤0.01%	3001
2016 Q2	$96K	Hold	18,900	–	–	﹤0.01%	3006
2016 Q1	$108K	Hold	18,900	–	–	﹤0.01%	2907
2015 Q4	$196K	Hold	18,900	–	–	﹤0.01%	2785
2015 Q3	$349K	Sell	18,900 -1,205	-6%	-$23.3K	﹤0.01%	2485
2015 Q2	$391K	Buy	+20,105	New	+$356K	﹤0.01%	2632

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

New York State Common Retirement Fund's OSIR Position: Q1 2017 in Review

New York State Common Retirement Fund sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 18,900 shares — an estimated $93K sold.

New York State Common Retirement Fund first reported a position in OSIR in Q2 2015 and held it in 7 quarters. The position peaked at $391K in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

New York State Common Retirement Fund reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
New York State Common Retirement Fund sold 18,900 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $93K.
New York State Common Retirement Fund first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
New York State Common Retirement Fund's Osiris Therapeutics, Inc. Common Stock position peaked at $391K in Q2 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on New York State Common Retirement Fund's 13F filing for Q1 2017, filed 15 May 2017.